Adaptive Biotechnologies Corporation (ADPT) Leapt 18% In Extended Trading. Here’s Why?
Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, has seen its share price surging 18.16% in extended trading to $49.90.
Best ESG Stocks to Look into Right Now
ESG companies carry strong environmental, social, and governance values while simultaneously gaining strong stock performance. Companies have turned towards incorporating these goals more after the signing of the Paris Climate Agreement in 2015 and as the world become more aware of the looming climate change crisis. ESG policies and practices help in measuring how much […]
